KIAM HONG PICADO: Open Payments
NPI 1851172126 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $497 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 6 | $235 |
| Actelion Pharmaceuticals US, Inc. | 7 | $140 |
| Astellas Pharma US Inc | 2 | $137 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| Grifols USA, LLC | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Baxter Healthcare | 2 | $38 |
Products named: Tyvaso, Cresemba, NUCALA, OPSUMIT, ARALAST, Prolastin-C Liquid, JASCAYD, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
